1,005 results on '"Peskind, Elaine R."'
Search Results
102. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
103. A Workshop on Cognitive Aging and Impairment in the 9/11-Exposed Population
104. The Relative Effects of Prazosin on Individual PTSD Symptoms: Evidence for Pathophysiologically-Related Clustering
105. Temporal Relationship Between Depression and Dementia: Findings From a Large Community-Based 15-Year Follow-up Study
106. Temporoparietal Hypometabolism in Frontotemporal Lobar Degeneration and Associated Imaging Diagnostic Errors
107. Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
108. Self-perceived irritability among OEF/OIF/OND veterans with a history of deployment-related mTBI: Associations with prospective memory and quality of life
109. Cognitive trajectory changes in African American veterans with combat PTSD
110. Repetitive but not single blast mild traumatic brain injury increases ethanol responsivity in mice and risky drinking behavior in combat Veterans
111. Alterations in Plasma microRNA and Protein Levels in War Veterans with Chronic Mild Traumatic Brain Injury
112. Increased Plasma Norepinephrine Response to Yohimbine in Elderly Men
113. Validation of Consensus Panel Diagnosis in Dementia
114. Age-Varying Association Between Statin Use and Incident Alzheimerʼs Disease
115. DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
116. Preclinical Evidence of Alzheimer Changes: Convergent Cerebrospinal Fluid Biomarker and Fluorodeoxyglucose Positron Emission Tomography Findings
117. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid
118. Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
119. Aging and Alzheimer's Disease
120. Age and Apolipoprotein E*4 Allele Effects on Cerebrospinal Fluid β-Amyloid 42 in Adults With Normal Cognition
121. Lewy Body Pathology in Familial Alzheimer Disease: Evidence for Disease- and Mutation-Specific Pathologic Phenotype
122. Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and β-Amyloid in Normal Adults
123. Effects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque
124. Chronic cortisol exposure promotes the development of a GABAergic phenotype in the primate hippocampus
125. The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months: A Long-term Extension Trial
126. Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal aging
127. Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study
128. Clinical and Neuropathological Characteristics of Hippocampal Sclerosis: A Community-Based Study
129. Human Glucocorticoid Feedback Inhibition Is Reduced in Older Individuals: Evening Study*
130. Management of Depression in Long-Term Care of Patients with Alzheimer's Disease
131. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease
132. The Utility of Apolipoprotein E Genotyping in the Diagnosis of Alzheimer Disease in a Community-Based Case Series
133. Preservation of Noradrenergic Neurons in the Locus Ceruleus that Coexpress Galanin mRNA in Alzheimer’s Disease
134. Clinico-Neuropathological Correlation of Alzheimer's Disease in a Community-Based Case Series
135. Repetitive blast promotes chronic aversion to neutral cues encountered in the peri-blast environment
136. Fine Particulate Matter Exposure and Cerebrospinal Fluid Markers of Vascular Injury
137. P3-265: DEVELOPMENT OF AN INDICATOR CELL ASSAY FOR BLOOD-BASED DIAGNOSIS OF ALZHEIMER'S DISEASE
138. P3-330: NON-INVASIVE IN VIVO MEASUREMENTS OF PARENCHYMAL GLYMPHATIC FLOW IN OLDER ADULTS
139. Variables associated with subjective cognitive change among Iraq and Afghanistan war Veterans with blast-related mild traumatic brain injury
140. Time will be of the essence in treating Alzheimer disease
141. Alzheimer's Disease and Other Dementing Disorders
142. Contributors
143. Pharmacologic treatments of dementia
144. Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease
145. Behavioral and Neuroendocrine Responses to Sodium Lactate Infusion in Subjects With Posttraumatic Stress Disorder
146. Effects of Alzheimer's Disease Severity on Cerebrospinal Fluid Norepinephrine Concentration
147. Effects of Alzheimer's Disease and Normal Aging on Cerebrospinal Fluid Norepinephrine Responses to Yohimbine and Clonidine
148. Sympathetic Nervous System Activity in Major Depression: Basal and Desipramine-Induced Alterations in Plasma Norepinephrine Kinetics
149. Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging
150. Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.